| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.42B | $2.67B | $2.96B |
| YoY Revenue Growth % | -9.4% | -9.7% | — |
| Gross Profit | $523.3M | $580.0M | — |
| Gross Margin % | 21.6% | 21.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $97.0M | $19.2M | $25.7M |
| Operating Margin % | 4.0% | 0.7% | 0.9% |
| Net Income (GAAP) | $27.0M | -$50.9M | -$55.4M |
| EBITDA (Normalized) | $133.2M | $65.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $95.9M | $112.9M | $147.6M |
| Capital Expenditures (CapEx) | $45.2M | $57.2M | — |
| Free Cash Flow (FCF) | $50.7M | $55.7M | $147.6M |
| FCF Margin % | 2.1% | 2.1% | 5.0% |
| Return on Invested Capital (ROIC %) | 19.7% | 4.1% | — |
| Cash & Short-Term Equivalents | $63.3M | $29.2M | — |
| Total Debt (Short + Long Term) | $322.9M | $349.1M | — |
| Total Stockholders' Equity | $128.6M | $49.9M | — |